GO:0031161 phosphatidylinositol catabolic process: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031161 phosphatidylinositol catabolic process describes the biochemical breakdown of phosphatidylinositol (PtdIns), a glycophospholipid whose sn-glycerol 3-phosphate is esterified to the 1-hydroxyl group of 1D-myo-inositol.
• Catabolism of PtdIns generates diacylglycerol (DAG) and inositol phosphates, which serve as second messengers in signal transduction and membrane trafficking.
• Phosphoinositide phosphatases, including myotubularin family enzymes, dephosphorylate 3-phosphoinositides and are central to PtdIns catabolic pathways.
• Dysregulation of phosphatidylinositol catabolism contributes to cancer, neurodegeneration, and immune disorders through altered phosphoinositide signaling.
• CRISPR knockout, point-mutation, and knock-in models enable causal dissection of genes encoding PtdIns-metabolizing enzymes.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to study phosphatidylinositol catabolic process in disease models.
Description
Phosphatidylinositol (PtdIns) is a minor but functionally critical membrane phospholipid that serves as a precursor for phosphoinositide signaling molecules. The Gene Ontology term GO:0031161, phosphatidylinositol catabolic process, defines the chemical reactions and pathways that result in the breakdown of PtdIns, a glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. This catabolic process is essential for terminating or modulating lipid-based signals and for recycling membrane components. Researchers study GO:0031161 because its products and intermediates influence diverse cellular processes, including vesicle trafficking, autophagy, and immune signaling. For example, phosphatidylinositol 3-phosphate (PI3P) synthesis and turnover are required for autophagosome formation and closure, linking PtdIns catabolism to autophagy. Moreover, phosphoinositide phosphatases that act on PtdIns derivatives are implicated in cancer and neuromuscular disorders. Understanding the enzymes, regulators, and downstream effectors of PtdIns catabolism provides mechanistic insight into membrane dynamics and offers therapeutic targets. This article synthesizes authoritative GO annotations and published literature to outline the definition, mechanisms, key genes, disease relevance, and research methods for GO:0031161.
phosphatidylinositol catabolic process At A Glance
| GO ID | GO:0031161 |
|---|---|
| GO term | phosphatidylinositol catabolic process |
| Ontology | biological_process |
| Synonym | phosphatidylinositol breakdown; phosphatidylinositol catabolism; phosphatidylinositol degradation; PtdIns catabolic process; PtdIns catabolism |
| Major function | Breakdown of phosphatidylinositol into diacylglycerol and inositol phosphates, modulating signaling and membrane lipid turnover |
| Key enzymes | Phospholipases, phosphoinositide phosphatases (e.g., myotubularins), and inositol polyphosphate phosphatases |
| Cellular location | Membrane compartments including plasma membrane, endosomes, and autophagosomes |
| Related pathways | Phosphoinositide signaling, autophagy, membrane trafficking, immune signaling |
What Is GO:0031161?
GO:0031161 phosphatidylinositol catabolic process is the set of biochemical reactions and pathways that degrade phosphatidylinositol, a glycophospholipid composed of sn-glycerol 3-phosphate esterified to the 1-hydroxyl group of 1D-myo-inositol and linked to fatty acid chains. Catabolism of PtdIns typically involves phospholipase-mediated hydrolysis to generate diacylglycerol and inositol phosphates, followed by further dephosphorylation and recycling of the inositol moiety. This process is distinct from the synthesis of PtdIns and from the catabolism of other phosphoinositides, although enzymes may overlap.
Why Is phosphatidylinositol catabolic process Important in Cell Biology?
Phosphatidylinositol catabolism is fundamental to cellular signaling and membrane homeostasis because it controls the levels of bioactive lipids such as diacylglycerol and inositol phosphates. These molecules regulate protein recruitment, kinase activation, and vesicle trafficking, and their dysregulation is linked to cancer, neurodegeneration, and immune dysfunction. Studying GO:0031161 helps researchers understand how cells terminate lipid signals and how defects in these pathways contribute to disease.
• Regulates second messenger levels (DAG, IP3) that control calcium signaling and protein kinase C activity.
• Controls autophagosome formation and closure via PI3P turnover.
• Modulates immune signaling through STING activation by phosphoinositides and cholesterol.
• Implicated in cancer through altered phosphoinositide phosphatase activity.
• Linked to neuromuscular disorders via myotubularin phosphatases.
• Affects membrane trafficking and endosomal dynamics.
• Provides targets for therapeutic intervention in metabolic and proliferative diseases.
• Enables CRISPR-based functional genomics of lipid metabolism.
• Supports research on nuclear lipid signaling.
• Helps interpret lipidomic and phosphoinositide profiling data.
What Happens During phosphatidylinositol catabolic process?
Hydrolysis of phosphatidylinositol by phospholipases
In simple terms: Enzymes cut the phosphatidylinositol molecule into smaller signaling pieces.
The first step in PtdIns catabolism often involves phospholipase C (PLC) or phospholipase D (PLD) activity, which hydrolyzes PtdIns to generate diacylglycerol (DAG) and inositol phosphates. These products act as second messengers, with DAG activating protein kinase C and inositol trisphosphate (IP3) releasing calcium from intracellular stores. This reaction is a key node in phosphoinositide signaling pathways.
Dephosphorylation of phosphoinositides by phosphatases
In simple terms: Phosphatases remove phosphate groups from modified phosphatidylinositol lipids.
Phosphoinositide phosphatases, such as myotubularin family enzymes, dephosphorylate 3-phosphoinositides, converting them to less phosphorylated forms and thereby terminating signals. These enzymes are critical for controlling the levels of PI3P and other phosphoinositides, and their dysfunction is associated with disease. The catabolic process ensures that phosphoinositide signals are spatially and temporally restricted.
Turnover of phosphatidylinositol 3-phosphate in autophagy
In simple terms: The breakdown of PI3P helps autophagosomes form and close properly.
Phosphatidylinositol 3-phosphate (PI3P) synthesis and turnover are required for autophagosome formation and closure. The transferrin receptor controls both autophagosome formation and closure via PI3P synthesis, indicating that catabolic enzymes that degrade PI3P are equally important for autophagy progression. This links GO:0031161 to autophagic flux and cellular quality control.
Regulation of STING activation by phosphoinositide catabolism
In simple terms: Breaking down certain lipids can switch immune signaling on or off.
Phosphoinositides and cholesterol regulate STING activation, a central adaptor in innate immune signaling. Catabolism of phosphatidylinositol and related lipids may influence the availability of phosphoinositides that modulate STING, thereby affecting immune responses. This connection highlights the role of PtdIns catabolism in host defense and inflammation.
Nuclear lipid signaling and inositol phosphate turnover
In simple terms: Lipid breakdown also happens in the nucleus and affects gene regulation.
Nuclear lipid signaling involves the metabolism of phosphatidylinositol and inositol phosphates, which can influence transcription and cell cycle progression. Catabolic enzymes in the nucleus contribute to the turnover of these lipids, thereby modulating nuclear signaling events. This underscores the compartmentalized nature of PtdIns catabolism.
Key Genes Involved in GO:0031161 phosphatidylinositol catabolic process
The following genes encode enzymes and regulators directly implicated in phosphatidylinositol catabolic process and related phosphoinositide turnover.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTM1 | Myotubularin phosphatase that dephosphorylates PI3P and PI(3,5)P2 | Mutations cause X-linked myotubular myopathy; model for phosphatase function |
| MTMR2 | Myotubularin-related phosphatase acting on 3-phosphoinositides | Linked to Charcot-Marie-Tooth disease; regulates endosomal trafficking |
| MTMR3 | Phosphatase that dephosphorylates PI3P and PI(3,5)P2 | Autophagy regulation and PI3P turnover |
| MTMR4 | Phosphatase involved in endosomal sorting | Modulates PI3P levels and signaling |
| MTMR6 | Phosphatase that acts on PI(3)P | Regulates ion channels and cell growth |
| MTMR7 | Phosphatase with specificity for PI(3)P | Neuronal function and lipid signaling |
| MTMR8 | Phosphatase that dephosphorylates PI(3)P | Cell migration and cytoskeletal dynamics |
| MTMR9 | Pseudophosphatase that regulates other myotubularins | Modulates enzyme activity in lipid catabolism |
| MTMR14 | Phosphatase acting on PI(3,5)P2 | Muscle function and autophagy |
| FIG4 | Phosphatase that dephosphorylates PI(3,5)P2 | Neurodegeneration and lysosomal function |
| INPP4A | Inositol polyphosphate 4-phosphatase | Hydrolyzes inositol phosphates derived from PtdIns |
| INPP4B | Inositol polyphosphate 4-phosphatase | Tumor suppressor in cancer; regulates PI(3,4)P2 |
| PTEN | Lipid phosphatase that dephosphorylates PI(3,4,5)P3 | Major tumor suppressor; indirectly affects PtdIns catabolism |
| PLCB1 | Phospholipase C beta 1 | Hydrolyzes PtdIns(4,5)P2 to DAG and IP3 |
| PLCG1 | Phospholipase C gamma 1 | Key enzyme in phosphoinositide signaling |
| PLD1 | Phospholipase D1 | Produces phosphatidic acid from PtdIns |
| SACM1L | Phosphatase that dephosphorylates PI(3)P and PI(4)P | Regulates autophagy and membrane trafficking |
| TFRC | Transferrin receptor | Controls autophagosome formation and closure via PI3P synthesis |
How Is phosphatidylinositol catabolic process Regulated?
Phosphatidylinositol catabolic process is regulated at multiple levels. Phosphoinositide phosphatases such as myotubularins are controlled by protein-protein interactions, phosphorylation, and lipid binding. The transferrin receptor modulates PI3P synthesis and turnover, thereby influencing autophagosome dynamics. Additionally, phosphoinositide phosphorylation can occur through non-kinase mechanisms, adding complexity to the regulation of PtdIns catabolism. Nuclear lipid signaling also contributes to spatial regulation of these reactions.
phosphatidylinositol catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTM1 | X-linked myotubular myopathy | Knockout mouse or patient iPSC-derived myotubes |
| MTMR2 | Charcot-Marie-Tooth disease type 4B1 | Knockout zebrafish or neuronal cultures |
| INPP4B | Cancer (tumor suppressor loss) | Knockout cancer cell lines and xenografts |
| PTEN | Cancer (Cowden syndrome, glioblastoma) | Conditional knockout mouse models |
| FIG4 | Neurodegeneration (ALS-like) | Knockout mouse and patient fibroblasts |
Cancer
Alterations in phosphoinositide phosphatases and phospholipases that catabolize PtdIns are frequently observed in cancer. For example, INPP4B acts as a tumor suppressor by dephosphorylating PI(3,4)P2, and its loss promotes oncogenic signaling. PTEN, a lipid phosphatase, is one of the most commonly mutated tumor suppressors and indirectly influences PtdIns catabolism by regulating PI(3,4,5)P3 levels. Targeting these enzymes is an active area of therapeutic research.
Neurodegeneration and neuromuscular disorders
Mutations in myotubularin-related genes, such as MTM1 and MTMR2, cause X-linked myotubular myopathy and Charcot-Marie-Tooth disease, respectively. These disorders highlight the importance of proper phosphoinositide catabolism in neuronal and muscle function. FIG4 mutations are also linked to neurodegeneration and lysosomal dysfunction.
Immune signaling and inflammation
Phosphoinositides and cholesterol regulate STING activation, which is critical for innate immunity. Catabolism of phosphatidylinositol may modulate the availability of phosphoinositides that influence STING, thereby affecting immune responses. Dysregulation of this process could contribute to autoinflammatory or immunodeficiency conditions.
Autophagy-related diseases
PI3P turnover is essential for autophagosome formation and closure, and defects in this process are linked to neurodegenerative and metabolic diseases. The transferrin receptor controls both autophagosome formation and closure via PI3P synthesis, indicating that catabolic enzymes that degrade PI3P are equally important. Thus, GO:0031161 is relevant to autophagy-related pathologies.
From phosphatidylinositol catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MTM1 alter PI3P levels and autophagy? | MTM1 knockout cell line (e.g., HeLa or C2C12) |
| How does a point mutation in INPP4B affect phosphatase activity? | Point-mutation knock-in via CRISPR in cancer cells |
| Can wild-type MTMR2 rescue neuronal defects? | Knock-in of tagged MTMR2 in patient iPSC-derived neurons |
| What is the interactome of myotubularin phosphatases? | Endogenous tagging (e.g., GFP knock-in) followed by immunoprecipitation |
| Does overexpression of PLCB1 increase DAG production? | Overexpression of PLCB1 in HEK293 cells |
| Which genes regulate autophagosome closure via PI3P? | CRISPR library screening in autophagy reporter cells |
How to Study the phosphatidylinositol catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS lipidomics | Quantification of PtdIns and catabolic products | Profiling lipid changes in knockout cells |
| Fluorescent PI3P biosensor | Real-time PI3P levels | Autophagosome formation and closure |
| CRISPR knockout screen | Gene essentiality for PtdIns catabolism | Identifying novel regulators |
| Phosphatase activity assay | Enzymatic dephosphorylation of phosphoinositides | Characterizing myotubularin mutants |
| Immunoprecipitation-mass spectrometry | Protein-protein interactions | Mapping catabolic enzyme complexes |
| RNA-seq | Transcriptional changes upon pathway perturbation | Assessing downstream signaling |
| FRET-based lipid sensors | Spatiotemporal lipid dynamics | Nuclear lipid signaling |
| Autophagy flux assay | Autophagosome turnover | Linking PtdIns catabolism to autophagy |
Lipidomics and phosphoinositide profiling
Mass spectrometry-based lipidomics can quantify phosphatidylinositol and its catabolic products, such as DAG and inositol phosphates. These methods are essential for measuring flux through GO:0031161 and for validating enzyme function. Phosphoinositide profiling using HPLC or LC-MS allows detection of specific phosphoinositide species.
Fluorescence microscopy and live-cell imaging
Genetically encoded biosensors (e.g., GFP-tagged PI3P-binding domains) enable real-time visualization of phosphoinositide dynamics during catabolism. Live-cell imaging can track autophagosome formation and closure in response to changes in PtdIns catabolism. Nuclear lipid signaling can be studied using FRET-based sensors.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for phosphatidylinositol catabolism and its downstream effects. Libraries targeting lipid kinases, phosphatases, and phospholipases enable systematic dissection of the pathway. Bioinformatics analysis of screening data reveals enriched pathways and candidate regulators.
Biochemical enzyme assays
In vitro phosphatase and phospholipase assays using radiolabeled or fluorescent substrates measure catalytic activity of enzymes like myotubularins and PLCs. These assays are critical for determining substrate specificity and kinetic parameters. They also help validate the effects of disease-associated mutations.
How CRISPR Can Be Used to Study GO:0031161 phosphatidylinositol catabolic process
Knockout
CRISPR knockout of genes encoding phosphatidylinositol catabolic enzymes, such as MTM1 or INPP4B, allows researchers to assess loss-of-function phenotypes. Knockout cell lines can be used to measure changes in phosphoinositide levels, autophagy flux, and signaling. These models are essential for validating gene function in disease contexts.
Point Mutation
Introducing disease-associated point mutations (e.g., in MTM1 or FIG4) via CRISPR base editing or homology-directed repair enables precise modeling of catalytic defects. Such models help distinguish loss-of-function from dominant-negative effects. They are valuable for testing targeted therapies.
Knock-in
Knock-in of tagged versions of catabolic enzymes (e.g., GFP-MTMR2) facilitates live-cell imaging and proteomic analysis. Knock-in of reporter cassettes can also be used to monitor pathway activity. These models preserve endogenous regulation and are ideal for studying subcellular localization.
Overexpression
Overexpression of phospholipases or phosphatases (e.g., PLCB1, PTEN) can amplify catabolic flux and reveal downstream consequences. Overexpression models are useful for gain-of-function studies and for testing inhibitors. They complement knockout approaches to establish causality.
How EDITGENE Supports phosphatidylinositol catabolic process Research
Researchers studying phosphatidylinositol catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid turnover, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol catabolic process research.
Frequently Asked Questions About phosphatidylinositol catabolic process
What is phosphatidylinositol catabolic process?
It is the biochemical breakdown of phosphatidylinositol, a membrane phospholipid, into diacylglycerol and inositol phosphates, as defined by GO:0031161.
What genes are involved in phosphatidylinositol catabolic process?
Key genes include MTM1, MTMR2, INPP4B, PTEN, PLCB1, and FIG4, which encode enzymes that hydrolyze or dephosphorylate phosphatidylinositol and its derivatives.
How is phosphatidylinositol catabolic process regulated?
It is regulated by protein-protein interactions, phosphorylation, and lipid binding of phosphatases, as well as by PI3P turnover during autophagy.
What diseases are linked to phosphatidylinositol catabolic process?
Dysregulation is linked to cancer, X-linked myotubular myopathy, Charcot-Marie-Tooth disease, and immune disorders.
What is the role of PI3P in autophagy?
PI3P synthesis and turnover are required for autophagosome formation and closure, linking PtdIns catabolism to autophagy.
How can I study phosphatidylinositol catabolic process using CRISPR?
CRISPR knockout, point-mutation knock-in, and overexpression models allow functional dissection of genes in this pathway.
What methods measure phosphatidylinositol catabolism?
Lipidomics, fluorescent biosensors, enzyme assays, and CRISPR screens are commonly used.
Which phosphatases act on 3-phosphoinositides?
Myotubularin family phosphatases, including MTM1, MTMR2, and MTMR3, dephosphorylate 3-phosphoinositides.
Is phosphatidylinositol catabolism involved in immune signaling?
Yes, phosphoinositides regulate STING activation, and their catabolism can influence innate immune responses.
What cell models are available for phosphatidylinositol catabolic process research?
EDITGENE offers knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening.
Conclusion
GO:0031161 phosphatidylinositol catabolic process is a fundamental biological process that controls the turnover of a key membrane phospholipid and its signaling derivatives. Its dysregulation is implicated in cancer, neurodegeneration, and immune disorders, making it a compelling area for mechanistic and therapeutic research. By leveraging CRISPR-based models and advanced lipidomics, researchers can dissect the enzymes and pathways that govern PtdIns catabolism. EDITGENE provides the tools and expertise to accelerate these discoveries.
References
- 1. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
- 3. Puri C et al.. 2025. Transferrin receptor controls both autophagosome formation and closure via phosphatidylinositol 3-phosphate synthesis.. Dev Cell 60(20):2715-2729.e8 PMID: 40543506
- 4. Rudge SA et al.. 2016. Phosphatidylinositolphosphate phosphatase activities and cancer.. J Lipid Res 57(2):176-92 PMID: 26302980
- 5. Cao X et al.. 2022. Phosphoinositide phosphorylation sans kinase.. Nat Cell Biol 24(5):604-606 PMID: 35484248
- 6. Tolias KF et al.. 1999. Pathways for phosphoinositide synthesis.. Chem Phys Lipids 98(1-2):69-77 PMID: 10358929
- 7. Irvine RF. 2003. Nuclear lipid signalling.. Nat Rev Mol Cell Biol 4(5):349-60 PMID: 12728269
- 8. Robinson FL et al.. 2006. Myotubularin phosphatases: policing 3-phosphoinositides.. Trends Cell Biol 16(8):403-12 PMID: 16828287
